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Abstract
Background: How to treat Major Depressive Disorder (MDD) in primary care? Studies that compared (brief)
Cognitive Behavioural Therapy (CBT) with care as usual by the General Practitioner (GP) found the first to be more
effective. However, to make a fair comparison GP care should be optimised and protocolised according to current
evidence based guidelines for depression. So far this has not been the case. We studied whether a protocolised 8
session CBT is more effective than optimised and protocolised GP care (GPC).
Methods: 121 patients with MDD, age 18-70 years, from 40 Dutch general practices, were randomised to either
brief CBT or GPC. Assessments were at baseline (t0), 12 weeks (t1) and 52 weeks (t2).
Main outcomes: decrease in depressive symptoms, response and remission on the Hamilton Depression Rating
Scale-17 (HDRS-17) and the Patient Health Questionnaire-9 (PHQ-9). (Trial registration: ISRCTN65811640).
Results: Both continuous and dichotomous HDRS-17 and PHQ-9 outcome scores favoured the brief CBT group.
Number of treatment contacts and external referrals were not different between groups. GPs prescribed
antidepressants (AD) to 48% of GPC patients and to 11% of CBT patients.
Conclusions: Brief CBT by psychologists seems more effective than optimized GPC. Effect sizes comparable to
the (statistical significant) results from meta-analyses, together with lower AD prescriptions, are both in favour of
brief CBT which might make it a first choice treatment for patients with MDD in general practice.
Keywords: Depressive disorder; Depression; Cognitive behaviour
therapy; Antidepressant agents; General practitioner; Randomised
controlled trial
Introduction
Major Depressive Disorder (MDD) is a heterogeneous illness with
quite different levels of severity and duration, varying numbers of
recurrences over the life-time and a ten percent risk for a chronic
course. The one year prevalence rates range from 4% to 8% in the
general population [1-3] and raise to 12% to 25% among primary care
(PC) populations across the world [4]. Related to this heterogeneity,
treatment of MDD differs widely in terms of method, intensity,
duration, setting and professional(s). Patients with severe, enduring or
highly recurrent MDD and those with complicating psychiatric and/or
somatic co-morbidity are mostly treated in specialized mental health
care settings. However the majority of patients suffer from mild to
moderate MDD and those are primarily treated in PC by their General
Practitioner (GP) or by mental health professionals, like psychologists
[5,6].
For mild to moderate severe MDD treatment guidelines from the
National Institute for Health and Clinical Excellence [7] and the
American Psychiatric Association [8] recommend low intensity
psychological therapy and only in some cases antidepressants (AD; e.g.
past history of severe MDD or inadequate response to initial
interventions). For moderate to severe MDD these guidelines
recommend AD, psychotherapy, or a combination of both. Of the
psychotherapeutic interventions for MDD Cognitive Behavioural
Therapy (CBT) so far has the most robust evidence [9-11].
CBT for primary care settings is mostly delivered in brief forms,
which include six to eight sessions [12-14], about ten sessions less than
the ‘classic’ CBT. In this form CBT is more suitable for PC settings and
more acceptable for PC patients. From an explanatory trial perspective
brief psychological interventions are better for a comparison with non-
psychological treatments than these classical longer ones, where
differences in the total amount of treatment and attention may be
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problematic when differences in outcome in favour of these
psychological treatments have to be interpreted [15].
Effectiveness studies and a recent meta-analysis showed that for
MDD patients brief CBT is more effective than treatment as usual by
GPs, especially during the first four months [16-20]. A limitation of
most comparisons of treatment as usual with an experimental
treatment is that the first are not standardised according to recent
clinical guideline recommendations with regard to what ‘optimal’
usual care should include. This unfair competiton may result in a
biased outcome; an overestimation of the effect of the experimental
treatment (CBT).
Protocolising treatment as usual and improving adherence to this
protocol are possible solutions to this methodological issue [21-24]. In
this study we did so by standardising the Dutch GP Practice Guideline
for MDD [25] and by giving GPs a short training in order to optimise
adherence to this protocol. We will refer to this intervention as
optimised general practitioners’ care (GPC). We hypothesised that




The study was conducted in patients of 40 general practices in two
parts of the Netherlands; West (Amsterdam region) and East
(Nijmegen region). Inclusion took place from January 2007 through
August 2010 and follow up assessment till August 2011. The study
protocol was approved by the institutional ethics review committees of
the Academic Medical Center in Amsterdam and the Radboud
University Medical Center in Nijmegen. More details of the study
design, including the content of the two treatments, can be found in
Baas et al. [26].
Participants and procedure
GPs referred patients with a possible MDD to the study centre.
Patients who gave informed consent for the diagnostic phase of the
study were assessed by telephone on demographics and clinical
characteristics within three days with the Structured Clinical Interview
for DSM-IV Axis I Disorders (SCID-I). Inclusion criteria were: MDD
and age between 18 and 70 years. Exclusion criteria were: mental
retardation, schizophrenia, bipolar disorder, severe suicidal thoughts,
terminal somatic illness, receiving active MDD treatment (a. use of
anti-depressive medication, b. psychotherapy, or c. supportive
consultations by the GP or social worker) and insufficient
comprehension of the Dutch or English language. Eligible patients
were next assessed with the Hamilton Depression Rating Scale-17
(HDRS-17) and the Patient Health Questionnaire-9 to establish the
severity of MDD. After that they were asked for participation in the
trial by their own GP.
Randomisation
After informed consent, the GP performed an internet based
randomisation procedure. A centralised computer program generated
a block randomisation of four blocks stratified by gender and location
(Nijmegen/Amsterdam) where the patient was randomised over the
two treatment strategies; optimised general practitioners’ care (GPC)
or brief cognitive behavioural therapy (CBT). The computer than
generated an outcome on the GP’s computer screen and
simultaneously send an email of this outcome to the researcher. In this
way, patients and investigators were not able to foresee the allocation.
Interventions
General practitioners’ care (GPC)
The GPC protocol (developed by HvW and AS; available on
request) was based on the Dutch College of General Practitioners
Practice Guideline (NHG-Standard) for depressive disorder [25]. GPC
had duration of 12 weeks and consisted of monitoring of symptoms,
psycho-education, discussion about possible causes or reasons of
MDD, problem solving techniques, life style advices and supportive
contacts. In accordance with the guidelines GPs were free to decide
whether they prescribed an antidepressant (AD) and if so which one.
Minimum frequency was one contact (10-15 minutes) every two weeks
during the first six weeks and one telephonic contact and one face-to-
face evaluation contact during the next 6 weeks. This number could be
increased in case of severity of symptoms and/or complaints and/or
lack of social support [26].
Brief cognitive behavioural therapy (brief CBT)
The brief CBT protocol (developed by CLHB; available on request)
consisted of eight sessions (50 minutes) within the 12 week period.
Treatment included behavioural activation and cognitive interventions
including identification and challenging of negative thoughts and
underlying attitudes and schemas [26]. Therapists were skilled
psychologists connected to one of the participating general practices.
They all were specifically trained in this brief CBT, had a Master in
Clinical Psychology and a four year post academic education in
behavioural therapy. They were all members of the Association of
Behavioural and Cognitive Therapy. CBT sessions were delivered at
the GPs practices.
All brief CBT sessions were audio-taped and treatment integrity
was assessed by checking whether the essential ingredients of the
intervention were present (behavioural activation, i.e. identification
and expanding of potentially pleasant activities and identifying and
challenging negative thoughts/ formulating rational thoughts) in a
random sample of 10% of each therapists tapes. Therapists had
intervision sessions (an organized meeting between colleagues in
which performed sessions and related problems are discussed) and
supervision sessions (an organized meeting between the therapist and
a supervisor, a fully trained cognitive behavioural therapist with a
Master in Clinical Psychology and a four year post academic education
in Behavioural Therapy and Clinical Psychology). During the 12-week
treatment period therapists were asked to refrain from referring the
patient to the GP for medication.
Measurements
Patients were assessed at three occasions: before randomisation
(baseline; t0); at the end of the treatment period (12 weeks; t1) and at
one year follow-up (52 weeks; t2).
Eligibility assessment:
The Structured Clinical Interview for DSM-IV Axis I Disorders
(SCID-I) is a semi-structured interview for diagnosing mental
disorders according to the DSM-IV criteria [27,28]. Throughout the
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study all SCID-I interviewers participated in ongoing training sessions
and monthly consensus meetings supervised by an expert psychiatrist
(JH) to maximize accuracy and consistency in the administration.
Outcome measures
As primary outcome we used a clinician-rated scale, the Hamilton
Depression Rating Scale-17 and a patient-rated scale, the Patient
Health Questionnaire-9. For both scales we measured continuous
outcomes and dichotomous outcomes (response, remission).
The Hamilton Depression Rating Scale-17 (HDRS-17; [29]) is a
well-known clinician rated, semi-structured clinical interview for
assessing the severity of depressive disorder which has good
psychometric properties [30]. In this study the HDRS was
administered by telephone [31] by three independent interviewers,
trained by an expert psychiatrist (JH). To maximize accuracy and
consistency in the administration we used the same training and
supervision procedure as with the SCID-I. The HDRS-17 total score
ranges from 0 to 52 points and is categorised as: 8-13, mild; 14-18,
moderate; 19-52, severe [32].
The Patient Health Questionnaire-9 (PHQ-9; [33,34]) is the 9 item
patient rated subscale of the Primary Care Evaluation of Mental
Disorders (PRIME-MD) which has good psychometric characteristics
[35] and connects well to primary care [36,37]. In this study the
PHQ-9 was send by mail. It evaluates the presence of the nine DSM-IV
criteria for a depressive episode. The sum score ranges from 0 to 27
and can be categorised as: 5-9, mild; 10-14, moderate; 15-19,
moderately severe; 20-27, severe). The PHQ-9 also offers a diagnostic
algorithm. A positive outcome on this algorithm requires that five or
more of the nine depressive symptom criteria of the DSM-IV are
present more than half the days in the past two weeks (suicidal
thoughts count if present at all), and at least one of these five or more
symptoms has to be depressed mood or anhedonia.
Dichotomous outcomes
Response: was defined as a total score reduction of >50% on the
HDRS-17 or the PHQ-9 [38-40]. Response was assessed only at the
end of treatment (12 weeks).
Remission: Using the HDRS-17, remission was defined as a total
score of 7 or less. For the PHQ-9 there is no consensus on the
definition of remission. To make comparisons with other studies
possible we applied two definitions. First, the original validation study
of the PHQ-9 [34] recommends that scores of 0-4 are in the minimal
depression range and scores of 5-9 are in the mild depression range.
We therefore defined remission as a score of <5. Second, the cut-off
value more widely used to identify a positive case for depressive
disorder is a total score of 10 or higher. We therefore also used a more
lenient, remission definition: a PHQ-9 total score <10 [39-41].
Remission was assessed both at 12 weeks (t1) and 52 weeks (t2).
Blinding
Interviewers were kept blind for the group assignment. They only
got the telephone number and name of the patient to be interviewed.
Before the interview patients were asked "not to reveal their treatment
condition". Interviewers were asked in the monthly consensus
meetings in how many cases the blinding was broken. They concluded
that in 85% to 95% of the cases patients had been able to retain the
concealment.
Treatment
In order to optimise GPC each participating GP received training
before the start of the study. During this one hour training we
educated the GP in the treatment protocol and discussed the content
of each of the contacts. After the training we provided a ring binder
with the treatment protocol (containing the content of each contact)
and informed the GP about the possibility of consulting an
independent physician for questions about the treatment protocol
during the intervention period.
To monitor the actual content of the provided GPC and potential
supplementary treatment next to GPC and brief CBT, GPs received a
questionnaire at the end of the 12 week treatment period (t1) in which
we asked how many appointments they had had with the patient,
whether they prescribed an antidepressant (+ type and dosage) and
whether they had referred CBT or GPC patients for supplementary
treatment to another health care professional.
Statistical Methods
To evaluate potential differences in baseline characteristics between
the two groups we used t-test for independent samples and the chi-
square test for categorical variables. When expected cell counts were
too small for the chi square test, Fishers exact test was used.
To take potential biased outcomes caused by selective loss to follow-
up into account we used multiple imputation (MI) which, assuming
missing at random (MAR) for missing values, gives unbiased results
with correct standard errors [42]. The results of the multiple
imputation analyses (5 imputed datasets) were combined using
Rubin’s rules [43]. F-test values and degrees of freedom were
calculated by the method proposed by Marshall et al. [44]. Since MI
based pooled estimates are considered less biased, all analyses are
based on the MI data. In the tables we show the estimates based on the
imputed data; in the legend of the tables the estimates based on the
actual observed data are presented. Furthermore, all analyses were
intention to treat. Analyses were carried out with SPSS Statistics 18.0.
To guard against an increased family wise error due to multiple testing
we corrected the significance threshold from .05 to .01. We used this
somewhat more lenient correction than the Bonferoni correction
because the 7 tests in our article were not independent (e.g. HDRS
score is correlated with PHQ score) which would make a Bonferoni
correction to strict and would result in an unnecessary loss of power.
Treatment effect
Continuous outcomes in HDRS-17 and PHQ-9 scores were
analyzed with a linear mixed model regression analysis with change
between t0 and t1 and change between t0 and t2 as dependent
variables, and treatment group, time and the treatment group by time
interaction as independent variables, and t0 severity (HDRS total
score) as covariate. In this model the main effect of treatment group
indicates treatment effect and the treatment by time interaction
indicates whether this effect sustains. When treatment by time
interaction was significant, we performed planned contrasts to assess
whether changes from t0 differed between both groups at t1 and at t2.
When the treatment by time interaction was not statistically
significant, we fitted a regression model without the interaction term
and present the effect estimate based on this model.
Percentage response was analyzed with logistic regression analysis
with response in terms of the HDRS-17 or the PHQ-9 as dependent
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variable and treatment group as independent variable, and baseline
severity as covariate. Percentage remission was analyzed with
longitudinal logistic regression analysis, using the SPSS Generalized
Estimating Equations programme (GEE) with a logit link function and
a binomial error distribution. Dependent variable was remission in
terms of the HDRS-17 or the PHQ-9. Independent variables were
treatment group, time, the treatment group by time interaction and t0
severity as covariate.
Results
Patient flow and demographic characteristics
Figure 1 shows the patient flow through the study [45]. During the
recruitment phase, 175 patients were referred; five patients (2.9%)
improved during recruitment and therefore declined participation;
170 could be assessed for eligibility. Of the 170 patients 34 (20%)
patients did not meet these criteria, eight (4.7%) patients refused
randomization due to treatment preference, six (3.5%) patients said
they were improved and therefore declined randomization, and one
(0.6%) patient did not accept the diagnosis of MDD; 121 (71.2%) met
the inclusion criteria and agreed to participate and to be randomised.
Data on outcome were obtained for 94 (78%) patients at 12 weeks and
for 77 (64%) patients at 52 weeks.
Figure 1: Patient flow according to the CONSORT criteria
Mean age of the total sample (n=121) was 45.1 years (s.d 11.2) and
66.9% of the patients were women (Table 1). Mean HDRS-17 score
was 19.1 (s.d 6.1) and mean PHQ-9 score was 17.8 (s.d 4.6), both on
the border of moderate and severe MDD. Almost half of the patients
(45.7%) had a recurrent MDD and one third (31.4%) suffered from a
co-morbid DSM-IV axis-I disorder (substance related disorder,
anxiety disorder, somatoform disorder). Both groups were comparable
on all demographic and clinical characteristics, both in terms of
statistical significance and effect size.
aGPC=general practitioners’ care; CBT=cognitive behavioural
therapy
bEducational attainment: three categories according to the Dutch
Educational System
cIncluding: substance related disorders, anxiety disorder, and
somatoform disorders
GPC a (n=61) CBT a (n=60)
Demographic characteristics 45.3 (11.0) 44.9 (11.6)
Age, mean (s.d)
Female % 72.1 61.7
Living situation %
- Alone 25.0 21.4
-With partner (with or without child) 50.1 55.4
-With child (without partner) 18.3 10.7
-With parent(s) 3.3 7.1
-Other 3.3 5.4
Caucasian % 78.3 78.6
Marital status %





- Employed 56.7 62.5
- Student 0.0 1.8
-Unemployed 26.7 23.2
- Retired 3.3 1.8
- Other 13.3 10.7
Educational attainmentb %
- Low 31.7 33.9
- Medium 48.3 41.1
- High 20.0 25.0
Clinical characteristics
Recurrent depression % 39.6 51.9
Severity depression (HDRS) %
- Mild (total score 8-13) 42.6 46.7
- Moderate (total score 14-18) 36.1 38.3
- Severe (total score 19-52) 21.3 15.0
HDRS-17, mean (s.d) 19.8 (6.4) 18.3 (5.8)
PHQ-9, mean (s.d) 18.3 (4.0) 17.4 (5.1)
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Co-morbid axis-I disorders, currentc % 32.8 30.0
Table 1: Baseline demographic and clinical characteristics (n=121)
Treatment Effect
Continuous outcomes
Table 2 shows that from t0 to t2 mean HDRS-17 scores declined
from 19.8 to 10.1 in the GPC group and from 18.3 to 8.2 in the brief
CBT group. Mean PHQ-9 scores declined from 18.3 to 9.4 in the GPC
group and from 17.4 to 7.1 in the brief CBT group. No significant
treatment by time interaction was found, neither for the HDRS-17, nor
for the PHQ-9.
Therefore we restricted ourselves to the regression model with only
the main effects. According to this model patients in the brief CBT
group improved on average 2.17 points more on the HDRS-17 total
score than patients in the GPC group (F(1, 18) = 1.96; 95% CI -0.86-
4.37; p=.178; Cohen‘s d: .36). Patients in the brief CBT group
improved 2.38 points more on the PHQ-9 total score compared to







HDRS-17(mean, s.d.) 1.96 (1,18) 0.178
Baseline (t0) 19.8 (6.4) 18.3 (5.8)
12 weeks (t1) 13.0 (8.5) 9.7 (7.4)
52 weeks (t2) 10.1 (9.0) 8.2 (6.9)
PHQ-9(mean, s.d.) 6.71 (1,320) 0.010
Baseline (t0) 18.3 (4.0) 17.4 (5.1)
12 weeks (t1) 11.2 (5.9) 8.3 (5.5)
52 weeks (t2) 9.4 (5.8) 7.1 (5.2)
Table 2: Continuous depression outcomea, b
aPresented are multiple imputation based pooled estimates
bObserved mean scores HDRS-17 (t0, t1, t2):
- GPC: 19.8 (n=61), 12.3 (n=49), 9.0 (n=41)
- CBT: 18.3 (n=60), 9.2 (n=45), 8.3 (n=37)
Observed mean scores PHQ-9 (t0, t1, t2):
- GPC: 18.3 (n=60), 11.1 (n=43), 8.9 (n=37)
- CBT: 17.4 (n=58), 7.7 (n=34), 6.7 (n=32)
cGPC=general practitioners’ care; CBT=cognitive behavioural
therapy
dLinear mixed model regression analysis with change between
baseline (t0) and 12 weeks (t1) and change between baseline (t0) and
52 weeks (t2) as dependent variables; treatment group, time and the
treatment group by time interaction as independent variables
ePooled multivariate test according to Marshall et al [44]
Dichotomous outcomes
Response: Table 3 shows that after 12 weeks of treatment on the
HDRS-17 a response was shown by 34.1% of the GPC group and by
48.7% of the brief CBT group. For the PHQ-9 responses were
respectively 39.3% and 57.0%. According to the logistic regression
model CBT and GPC patients did not differ in response percentage on
the HDRS-17 (odds ratio 1.90; F (1, 1183)= 2.70; 95% CI 0.88- 4.09;
p=.100; Cohen‘s h: .30), nor on the PHQ-9 (odds ratio 2.22; F (1,
83)=3.42; 95% CI 0.95- 5.14; p=.068; Cohen‘s h: .36).
Remission: Based on HDRS-17 scores 32.5% of the patients in the
GPC group and 51.7% in the brief CBT group could be considered a
remitter at 12 weeks and respectively 44.6%and 55.7% at 52 weeks. The
logistic regression without treatment by time interaction showed no
significant relation between treatment type and HDRS-17 remission
(odds ratio 1.97; F(1, 34)= 2.49; 95% CI 0.87- 3.70; p=.124). For the
PHQ-9 cut off <10 these figures were respectively 42.6% and 57.3% at
12 weeks and 54.8% and 71.7% at 52 weeks. Logistic regression
without treatment by time interaction showed no significant relation
between treatment type and PHQ-9 remission when using <10 as cut
off score (odds ratio 2.14; F(1, 268)= 3.52; 95% CI 0.95-4.83; p=0.062),
nor when remission was defined as a PHQ score <5 (odds ratio 1.87; F
(1,67)=3.42; 95% CI 0.97-3.63; p=0.069). In the latter case MI based
remission rates were respectively 10.8% (GPC) and 30.0% (CBT) at 12





F(df1,df2)d,e Pd,e effect sizeh
Responsef(at
12weeks; t1)
HDRS-17 34.1% 48.7% 2.70(1,1183) 0.100 0.30
PHQ-9 39.3% 57.0% 3.42(1,83) 0.068 0.36
Remissiong
HDRS-17 2.49(1,34) 0.124
12 weeks (t1) 32.5% 51.7% 0.39
52 weeks (t2) 44.6% 55.7% 0.22
PHQ-9 (<10) 3.52(1,268) 0.062
12 weeks (t1) 42.6% 57.3% 0.30
52 weeks (t2) 54.8% 71.7% 0.35
PHQ-9 (<5) 3.42(1,67) 0.069
12 weeks (t1) 10.8% 30.0% 0.49
52 weeks (t2) 23.0% 33.0% 0.22
Table 3: Dichotomous depression outcome: response and remissiona,b
aPresented are multiple imputation based pooled estimates
bObserved percentages response (12 weeks; t1):
- HDRS-17: GPC 36.7%, CBT 51.1%
- PHQ-9: GPC 39.5%, CBT: 61.8
Observed percentages remission (12 weeks; t1):
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- HDRS-17: GPC 36.7%, CBT 55.6%
- PHQ-9 (<10): GPC 44.2%, CBT 61.8%
- PHQ-9(<5): GPC 11.6%, CBT 35.3%
Observed percentages remission (52 weeks; t2):
- HDRS-17: GPC 51.2%, CBT 56.8%
- PHQ-9 (<10): GPC 59.5%, CBT 75.0%
- PHQ-9 (<5): GPC 27.3%, CBT 37.5%
cGPC=general practitioners’ care; CBT=cognitive behavioural
therapy
dResponse: logistic regression analysis with response (Y/N) as
outcome variable and treatment as dependent variable; Remission:
GEE analysis with remission (Y/N) as dependent and treatment and
time as independent variables (treatment by time interaction was not
significant)
ePooled multivariate test according to Marshall et al. [44]
fResponse: > 50% decrease of the baseline score (t0)
gRemission: HDRS-17 score ≤7; PHQ-9 score <10; PHQ-9 score<5
hCohen’s d (0.20 = small; 0.50 = medium, 0.80 = large)
Adherence and Antidepressant Use
Patients in the brief CBT group received a mean of 6.1 sessions with
the psychologist (range 0-8; s.d 2.7). Three patients did not attend any
treatment session. The most common reason for termination of
therapy was lack of motivation to attend the sessions. Patients in the
GPC group received a mean of 4.9 appointments with their GP (range
1-12; s.d 2.2). All patients attended at least one GP-appointment.
Treatment integrity assessment of CBT showed that the essential
ingredients of the intervention (i.e. behavioural activation and
challenging negative thoughts/ formulating rational thoughts) were
present. No interference in the work procedures of the psychologists
was necessary.
GPs prescribed antidepressants to 48% of the GPC patients and to
11% of the CBT patients. In total one in seven patients received an
outside referral for additional mental health treatment (11% in brief
CBT and 18% in GPC).
Discussion
We investigated whether brief cognitive behavioural therapy (CBT)
applied by psychologists was more effective than optimised and
protocolised general practitioners’ care (GPC), based on a GP
treatment guideline for primary care patients with MDD. Over the full
52 weeks follow up the depression severity in both groups reduced to
about half of the baseline value. Both on the HDRS-17 interview and
the PHQ-9 self-rating about 70% of this improvement was between
baseline (t0) and the end of treatment at 12 weeks (t1). Our study
shows that CBT is at least as effective as GPC (both treatments did not
differ on the dichotomous outcomes: response at t1 on HDRS and
PHQ-9, and remission on t1 and t2 on HDRS and PHQ-9) and gives
an indication that CBT is perhaps more effective (improvement on the
mean PHQ-9 score differed significantly between both groups in
favour of brief CBT [effect size: .51] and the combined overall trend
appears to consistently favour brief CBT). Till now effectiveness
studies and a recent meta-analysis showed that brief CBT is more
effective than treatment as usual by GPs. We studied an optimized
form of GP care and conclude that brief CBT is just as good and
perhaps better.
It cannot be ruled out that due to the sample size our tests had
insufficient power to detect effects of the observed magnitude. This is
supported by the fact that our effect sizes (most between .30 and .50)
are comparable in magnitude to the statistical significant pooled effect
sizes of three meta-analyses of CBT versus usual care [20,46,47] which
were all in favour of CBT and were in the range of 0.33 to 0.42. Given
the effect sizes it is not unreasonable to expect that we might have
found more statistical significant effects of treatment type with a larger
sample size although such a larger sample size might reduce effect sizes
[11].
For the PHQ-9 we used two remission rates and found that those
based on the definition of a PHQ-9 cut off <10 were more comparable
to the HDRS-17 remission rates than those based on the definition of a
PHQ-9 cut off <5. Compared to HDRS-17 the first one (<10) seems to
overestimate remission by some 10%, while the second one (<5)
underestimates remission by some 20%.
Our remission data at 52 weeks follow up need some explanation.
First it is known that 50% of depressive episodes will be in remission at
three months, but another 25% will last longer than 12 months [48]. It
is also known that during the first year the proportion of patients
relapsing/recurring is 25% [49]. To consider a new period of
depression as a real recurrence the DSM IV states that between
episodes ‘there must be an interval of at least 2 consecutive months in
which criteria are not met for a Major Depressive Episode’.
Unfortunately we were not able to assess relapses or recurrences of
depression in that detail over the t1-t2 period. We only know that
non-remission (considering PHQ-9 cut off <10 and HDRS-17) at 52
weeks was in the 28-44% range for CBT and in the 45-55% range for
GPC. Whether this non-remission was related to ‘real’ non-remission,
relapse or recurrence is not known.
This issue of remission/recurrence of course is interesting because
one important advantage of CBT in comparison with AD is its
prophylactic effect on depression recurrence after acute CBT/AD
treatment has been stopped [49-51]. However in almost all studies on
this prophylactic aspect, CBT was of the 16-18 sessions type, as was
common for the acute treatment of CBT, and so it remains unclear
whether the brief CBT we studied also has an enduring effect.
Patients in de brief CBT group received six therapy sessions
(sometimes called ultra-brief CGT; [52]), about two sessions less than
the intended and protocolised eight sessions which is in line with other
primary care studies on brief CBT in primary care [13,20]. The five
(face to face or telephonic) appointments of the GPC patients
correspond to the recommended number in the protocol. During the
12 week treatment phase patients in the GPC group received one
session less than the brief CBT patients which suggest a comparable
number of professional contacts in both groups. Furthermore the
referral rate to other mental health treatments was also comparable;
one in seven patients in both groups.
Anti-depressants (AD) were one of the treatment options in the
GPC. The GPs were educated in the treatment protocol and they
received feedback of the SCID-I and HDRS interview results (i.e.
diagnosis and severity of MDD). By this procedure they were in an
optimal condition to decide to prescribe ADs in accordance with the
primary care guidelines. This finally resulted in 48% of AD
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prescriptions in the GPC group. We think this percentage is in
accordance with the depressions severity at baseline, but rather low
compared to other GP studies where 49-96% of the patients received
ADs [17,53-55].
Interestingly we have to conclude that the somewhat better
depression outcome was accomplished with a small percentage of AD
prescriptions (11%) in the brief CBT group. Since studies showed that
patients generally prefer psychological therapy to pharmacological
therapy [56-59], this low AD prescription may be another advantage of
brief CBT. However, we have no assessment of patient’ preference or
satisfaction, and so this advantage is not proven in our sample.
Earlier studies on brief CBT in depressed PC patients are scarce and
showed brief CBT to be more effective than treatment as usual,
especially in the short term, but the advantages were small [16-18,47].
Our study differs from these earlier studies in several ways. First, we
optimised treatment as usual by using the treatment protocol and the
GP training. By this, we think our study design results in a more valid
comparison and consequently more valid estimate of the differences in
treatment effects between brief CBT and GPC. To our knowledge only
one other study also educated GPs; Conradi et al. [19] invited GPs to
attend a 2-hour booster session about guidelines for the treatment of
depression. Second, the number of offered sessions of the brief CBT
differed. In two of the earlier studies brief CBT consisted of ten or
more sessions (range 10-12 sessions; [16,19]), while we finally used the
six sessions found in clinical practice. Furthermore, the content of the
brief CBT differed. Scott et al. [17], for instance, used mainly cognitive
techniques instead of a mixture of cognitive and behavioural aspects as
we did. Finally, the way the severity of depression was assessed
differed. Only one study used both a patient rated and a clinician rated
instrument [17]. The other studies used either a clinician rated
instrument (HDRS-17; [16]) or a patient rated instrument (Beck
Depression Inventory [60]). A recent meta-analysis showed that
clinician-rated and patient-reported measures of improvement in
depression studies are not equivalent and the authors recommended
using both [14] as we did.
Strengths and limitations
Our study has limitations. First, one could argue that a control or
treatment as usual group should have been included. We think that
CBT had already been proven effective as compared to care as usual
[20] and so we considered a placebo or control group not necessary
and even unethical. Second, we obtained no information about harms
(adverse effects) of the GPC while, for example, side effects of
medication can have an influence on whether an intervention will be
acceptable. Third, although we tried hard, we were not successful to
measure adherence to the GPC protocol because this measure was too
time-consuming for busy GPs. However, we monitored the actual
content of the provided GPC by sending each GP a short
questionnaire at the end of the intervention period in which we asked
how many appointments they had had with the patient, whether they
prescribed an antidepressant and whether they referred patients to
another health care professional. This provided a global estimate of
adherence to the protocol. Fourth, we did not measure the total
amount of treatment patients in both conditions received between 12
weeks and follow-up at 52 weeks. Finally, we did use multiple
imputations (MI) which requires the missing mechanism to be
missing at random (MAR). Unfortunately, the MAR assumption is not
testable [62]. Serious violations of MAR are, however, unlikely and
lesser violations are only problematic in specific situations that are also
rare [63-65]. Alternatives to MI like complete cases analysis or mixed
model regression analysis on the observed data either are much more
likely to lead to biased results (complete cases analysis) or also require
MAR (mixed model regression).Even though we used the best method
we cannot completely rule out that the MAR assumption violations
induced some bias. However, even in this case the results after MI are
most likely less biased than the results from the observed data.
Strengths of this study are the adequate randomisation procedure,
the follow-up of 52 weeks, the assessment of AD prescriptions and the
detailed analyses of treatment effects. We have tried to improve
generalizability by including a great number of general practices from
two geographical areas and by using lenient inclusion criteria,
permitting co-morbidity [61,62]. Finally the optimisation and
standardisation of the GP treatment and the limitations for external
referrals allowed a fairer comparison.
Conclusion
We conclude that compared to optimised GPC the brief CBT we
developed is probably more successful on depression outcome. This
finding, together with a substantial reduction of AD prescriptions in
the brief CBT group and the similarity of our effect sizes to the
(statistical significant) pooled effect sizes of three meta-analyses of
CBT versus usual care, makes brief CBT a good first choice treatment
for PC patients with MDD. For the majority of patients a primary care
intervention seemed sufficient. One in seven patients was referred for
additional therapy. However further trials are needed to support the
probable superiority of brief CBT in comparison to optimized GP care
and to examine the relative cost-effectiveness.
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